Skip to main content
Aligned Genetics, Inc. logo

Aligned Genetics, Inc. — Investor Relations & Filings

Ticker · 238120 ISIN · KR7238120000 KO Manufacturing
Open in API
Filings indexed 140 across all filing types
Latest filing 2019-03-12 AGM Information
Country KR South Korea
Listing KO 238120

About Aligned Genetics, Inc.

https://en.alignedgenetics.com

Aligned Genetics, Inc. is a company that develops, manufactures, and sells advanced solutions for cellular imaging, biomolecular analysis, and molecular diagnostics. It provides cutting-edge equipment, automated systems, imaging instruments, and reagents for laboratories in the life science and medical fields. The company focuses on developing molecular diagnostic solutions that deliver rapid and accurate results to support faster clinical care. Aligned Genetics aims to improve human health by creating technologies that offer deeper insights into cellular and molecular processes.

Recent filings

Filing Released Lang Actions
주주총회소집공고
AGM Information Classification · 100% confidence The document is a 'Notice of Convocation of the Annual General Meeting' (주주총회소집공고) for Logos Biosystems. It contains the agenda for the meeting, including the approval of financial statements, election of directors, and remuneration limits. It also includes detailed financial statements (balance sheet, income statement, cash flow, etc.) as part of the management's reference materials for shareholders. Since this document is the official notice and accompanying materials for an upcoming Annual General Meeting, it is classified as AGM Information.
2019-03-12 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Logos Bio. It outlines the date, location, and agenda items (such as approval of financial statements, appointment of directors/auditors, and remuneration limits). This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of upcoming voting matters, which falls under the Proxy Solicitation & Information Statement category.
2019-02-12 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed under the Capital Markets Act in South Korea. This type of filing is used to report changes in shareholdings by major shareholders or insiders. In the provided taxonomy, this corresponds to 'Major Shareholding Notification' (MRQ), as it details the change in ownership percentage of a major shareholder (Partners Investment Co., Ltd.) in the issuing company (Logos BioSystems).
2019-01-04 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory notice regarding the suspension of share registration (shareholder register closure) for the purpose of determining shareholders eligible to vote at the 11th Annual General Meeting. It does not contain the full report or financial statements, but rather serves as a formal regulatory announcement of a corporate action. Given it does not fit into specific categories like dividend announcements or share buybacks, it falls under the general regulatory filing category.
2018-12-14 Korean
분기보고서 (2018.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Logos Biosystems, covering the period from January 1, 2018, to September 30, 2018. It contains detailed financial statements, management discussion and analysis, and operational information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2018
2018-11-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.